• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4615178)   Today's Articles (4364)   Subscriber (49391)
For: Kumar V, Singh A. Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: An opinion. EXCLI J 2021;20:1086-1090. [PMID: 34267617 PMCID: PMC8278213 DOI: 10.17179/excli2021-3670] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Accepted: 06/04/2021] [Indexed: 11/24/2022]
Number Cited by Other Article(s)
1
Kumar V, Kaur S, Kapil L, Singh C, Singh A. HDAC11: A novel inflammatory biomarker in Huntington's disease. EXCLI JOURNAL 2022;21:647-650. [PMID: 35651655 PMCID: PMC9149973 DOI: 10.17179/excli2022-4741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Accepted: 03/16/2022] [Indexed: 11/08/2022]
2
Kumar V, Singh C, Singh A. Zebrafish an experimental model of Huntington's disease: molecular aspects, therapeutic targets and current challenges. Mol Biol Rep 2021;48:8181-8194. [PMID: 34665402 DOI: 10.1007/s11033-021-06787-y] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2021] [Accepted: 09/17/2021] [Indexed: 12/13/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA